{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:47:09Z","timestamp":1782564429948,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100008685","name":"Universiti Pendidikan Sultan Idris","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008685","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12175-1","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:06:53Z","timestamp":1782562013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular dissection of CD28-associated cytokine signaling in early psoriasis"],"prefix":"10.1007","volume":"53","author":[{"given":"Shahad Basil","family":"Ismael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawaa","family":"AlChalabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saja Ali","family":"Shareef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jabir","family":"Majid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russul","family":"AlObaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5705-0223","authenticated-orcid":false,"given":"Jameel R.","family":"Al-Obaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"issue":"3","key":"12175_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.disamonth.2018.06.001","volume":"65","author":"ED Schadler","year":"2019","unstructured":"Schadler ED, Ortel B, Mehlis SL (2019) Biologics for the primary care physician: Review and treatment of psoriasis. Dis Mon 65(3):51\u201390. https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0011502918300956","journal-title":"Dis Mon"},{"issue":"2","key":"12175_CR2","doi-asserted-by":"publisher","first-page":"e079627","DOI":"10.1136\/bmjopen-2023-079627","volume":"14","author":"Z Yang","year":"2024","unstructured":"Yang Z, Jin Y, Wang M, Li R, Li WQ, Li H (2024) Enhanced impact of psoriasis severity on the treatment demands of patients during the COVID-19 pandemic: a cross-sectional study based on a national psoriasis registry in China. BMJ open 14(2):e079627. https:\/\/doi.org\/10.1136\/bmjopen-2023-079627","journal-title":"BMJ open"},{"issue":"4","key":"12175_CR3","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.51248\/.v43i4.3111","volume":"43","author":"RS Mahdi","year":"2023","unstructured":"Mahdi RS, Salman MI, AlChalabi R (2023) Serum level of certain cytokines associated with psoriasis progression in Iraqi patients. Biomedicine 43(4):1252\u20131255. https:\/\/doi.org\/10.51248\/.v43i4.3111","journal-title":"Biomedicine"},{"issue":"4","key":"12175_CR4","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.pathol.2023.10.009","volume":"56","author":"C Grolleau","year":"2024","unstructured":"Grolleau C, Bettuzzi T, Wang L, Wolkenstein P, Sbidian E, Ortonne N (2024) Guttate psoriasis shares histological features with pustular psoriasis and often shows neutrophil exocytosis and pustules. Pathology 56(4):606\u2013608. https:\/\/www.pathologyjournal.rcpa.edu.au\/article\/S00313025(23)00306-9\/fulltext","journal-title":"Pathology"},{"key":"12175_CR5","doi-asserted-by":"publisher","first-page":"107802","DOI":"10.1016\/j.jmgm.2020.107802","volume":"103","author":"P Krupa","year":"2021","unstructured":"Krupa P, Spodzieja M, Sieradzan AK (2021) Prediction of CD28-CD86 protein complex structure using different level of resolution approach. J Mol Graph Model 103:107802. https:\/\/doi.org\/10.1016\/j.jmgm.2020.107802","journal-title":"J Mol Graph Model"},{"key":"12175_CR6","doi-asserted-by":"publisher","unstructured":"Khopanlert W, Choochuen P, Maneechai K, Jangphattananont N, Ung S, Okuno S et al (2024). Co-stimulation of CD28\/CD40 signaling molecule potentiates CAR-T cell efficacy and stemness. Molecular Therapy Oncology, 32(3). https:\/\/doi.org\/10.1016\/j.omton.2024.200837","DOI":"10.1016\/j.omton.2024.200837"},{"key":"12175_CR7","doi-asserted-by":"publisher","unstructured":"Li Y, Jin L, Yan J, Zhang H, Zhang R, Hu C (2021) CD28 Genetic variants increase susceptibility to diabetic kidney disease in chinese patients with Type 2 diabetes: A Cross-Sectional Case Control Study. Mediators Inflamm (5521050). https:\/\/doi.org\/10.1155\/2021\/5521050","DOI":"10.1155\/2021\/5521050"},{"key":"12175_CR8","doi-asserted-by":"publisher","unstructured":"Santiago JL, S\u00e1nchez-P\u00e9rez L, P\u00e9rez-Flores I, de la Higuera MAM, Romero NC, Querol-Garc\u00eda J et al. (2021). Association of polymorphisms in T-cell activation costimulatory\/inhibitory signal genes with allograft kidney rejection risk. Frontiers in Immunology, 12, 650979. https:\/\/doi.org\/10.3389\/fimmu.2021.650979","DOI":"10.3389\/fimmu.2021.650979"},{"key":"12175_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12979-023-00405-0","volume":"21","author":"A Aprilia","year":"2024","unstructured":"Aprilia A, Handono K, Sujuti H et al (2024) sCD163, sCD28, sCD80, and sCTLA-4 as soluble marker candidates for detecting immunosenescence. Immun Ageing 21:9. https:\/\/doi.org\/10.1186\/s12979-023-00405-0","journal-title":"Immun Ageing"},{"issue":"12","key":"12175_CR10","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/hmg\/ddn077","volume":"17","author":"VB Guzman","year":"2008","unstructured":"Guzman VB, Yambartsev A, Goncalves-Primo A, Silva ID, Carvalho CR, Ribalta JC, Goulart LR, Shulzhenko N, Gerbase-Delima M, Morgun A (2008) New approach reveals CD28 and IFNG gene interaction in the susceptibility to cervical cancer. Hum Mol Genet 17(12):1838\u20131844. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2536747\/","journal-title":"Hum Mol Genet"},{"key":"12175_CR11","doi-asserted-by":"publisher","first-page":"6601","DOI":"10.1038\/s41598-022-10631-z","volume":"12","author":"DP Chen","year":"2022","unstructured":"Chen DP, Lin WT, Wen YH et al (2022) Investigation of the correlation between immune thrombocytopenia and T cell activity-regulated gene polymorphism using functional study. Sci Rep 12:6601. https:\/\/doi.org\/10.1038\/s41598-022-10631-z","journal-title":"Sci Rep"},{"issue":"2","key":"12175_CR12","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.3390\/ijms25021274","volume":"25","author":"K Ciesielska-Figlon","year":"2024","unstructured":"Ciesielska-Figlon K, Lisowska KA (2024) The role of the CD28 family receptors in T-cell immunomodulation. Int J Mol Sci 25(2):1274. https:\/\/doi.org\/10.3390\/ijms25021274","journal-title":"Int J Mol Sci"},{"issue":"3","key":"12175_CR13","doi-asserted-by":"publisher","first-page":"691","DOI":"10.4103\/MJBL.MJBL_1459_23","volume":"21","author":"SH Farhan","year":"2024","unstructured":"Farhan SH, Mahmood SH, Baqer NN (2024) The Incidence of CD28 Gene Polymorphism (rs3116496) and Gene Expression with Oral Carcinoma in Some Iraqi Samples. Med J Babylon 21(3):691\u2013695. https:\/\/journals.lww.com\/mjby\/fulltext\/2024\/21030\/the_incidence_of_cd28_gene_polymorphism.33.aspx?context=latestarticles","journal-title":"Med J Babylon"},{"key":"12175_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/bs.acc.2020.04.004","volume":"100","author":"CC de Alcantara","year":"2021","unstructured":"de Alcantara CC, Reiche EMV, Sim\u00e3o ANC (2021) Cytokines in psoriasis. Adv Clin Chem 100:171\u2013204. https:\/\/pubmed.ncbi.nlm.nih.gov\/33453865\/","journal-title":"Adv Clin Chem"},{"issue":"10","key":"12175_CR15","doi-asserted-by":"publisher","first-page":"e0293327","DOI":"10.1371\/journal.pone.0293327","volume":"18","author":"XQ Liu","year":"2023","unstructured":"Liu XQ, Zhou PL, Yin XY, Wang AX, Wang DH, Yang Y, Liu Q (2023) Circulating inflammatory cytokines and psoriasis risk: A systematic review and meta-analysis. PLoS ONE 18(10):e0293327. https:\/\/doi.org\/10.1371\/journal.pone.0293327","journal-title":"PLoS ONE"},{"issue":"23","key":"12175_CR16","doi-asserted-by":"publisher","first-page":"12793","DOI":"10.3390\/ijms222312793","volume":"22","author":"R Singh","year":"2021","unstructured":"Singh R, Koppu S, Perche PO, Feldman SR (2021) The cytokine mediated molecular pathophysiology of psoriasis and its clinical implications. Int J Mol Sci 22(23):12793. https:\/\/doi.org\/10.3390\/ijms222312793","journal-title":"Int J Mol Sci"},{"issue":"2","key":"12175_CR17","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.cyto.2014.12.014","volume":"73","author":"J Baliwag","year":"2015","unstructured":"Baliwag J, Barnes DH, Johnston A (2015) Cytokines in psoriasis. Cytokine 73(2):342\u2013350. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4437803\/","journal-title":"Cytokine"},{"issue":"5","key":"12175_CR18","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/medicina60050815","volume":"60","author":"M Zalesak","year":"2024","unstructured":"Zalesak M, Danisovic L, Harsanyi S (2024) Psoriasis and psoriatic arthritis-associated genes, cytokines, and human leukocyte antigens. Med (Kaunas) 60(5):815. https:\/\/doi.org\/10.3390\/medicina60050815","journal-title":"Med (Kaunas)"},{"issue":"11","key":"12175_CR19","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/s41419-018-1143-3","volume":"9","author":"L Mercurio","year":"2018","unstructured":"Mercurio L, Morelli M, Scarponi C, Eisenmesser EZ, Doti N, Pagnanelli G, Gubinelli E, Mazzanti C, Cavani A, Ruvo M, Dinarello CA, Albanesi C, Madonna S (2018) IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment. Cell Death Dis 9(11):1104. https:\/\/doi.org\/10.1038\/s41419-018-1143-3","journal-title":"Cell Death Dis"},{"key":"12175_CR20","doi-asserted-by":"publisher","first-page":"1387921","DOI":"10.3389\/fimmu.2024.1387921","volume":"15","author":"A Huard","year":"2024","unstructured":"Huard A, Rodriguez E, Talabot-Ayer D, Weigert A, Palmer G (2024) Interleukin-38 overexpression in keratinocytes limits desquamation but does not affect the global severity of imiquimod-induced skin inflammation in mice. Front Immunol 15:1387921. https:\/\/doi.org\/10.3389\/fimmu.2024.1387921","journal-title":"Front Immunol"},{"key":"12175_CR21","doi-asserted-by":"publisher","unstructured":"Wang X, Wei Y, Xiao H, Liu X, Zhang Y, Han G et al (2016). A novel IL-23p19\/Ebi3 (IL\u201039) cytokine mediates inflammation in Lupus\u2010like mice. European journal of immunology, 46(6), 1343\u20131350. https:\/\/doi.org\/10.1002\/eji.201546095","DOI":"10.1002\/eji.201546095"},{"key":"12175_CR22","doi-asserted-by":"publisher","unstructured":"Al Ghuraibawi ZAG, Sharquie IK, Gorial FI (2023) A novel link of serum IL-39 levels in patients with rheumatoid arthritis. Iraqi J Sci 1651\u20131661. https:\/\/doi.org\/10.24996\/ijs.2023.64.4.8","DOI":"10.24996\/ijs.2023.64.4.8"},{"key":"12175_CR23","doi-asserted-by":"publisher","first-page":"110616","DOI":"10.1016\/j.clinbiochem.2023.110616","volume":"119","author":"L Ying","year":"2023","unstructured":"Ying L, Gong L, Meng S, Wu X, Li M, Li Y (2023) Circulating interleukin-39 as a potential biomarker for rheumatoid arthritis diagnosis. Clin Biochem 119:110616. https:\/\/doi.org\/10.1016\/j.clinbiochem.2023.110616","journal-title":"Clin Biochem"},{"issue":"3","key":"12175_CR24","doi-asserted-by":"publisher","first-page":"e409","DOI":"10.1002\/edm2.409","volume":"6","author":"SW Nussrat","year":"2023","unstructured":"Nussrat SW, Ad\u2019hiah AH (2023) Interleukin-39 is a novel cytokine associated with type 2 diabetes mellitus and positively correlated with body mass index. Endocrinol diabetes metabolism 6(3):e409. https:\/\/doi.org\/10.1002\/edm2.409","journal-title":"Endocrinol diabetes metabolism"},{"issue":"2","key":"12175_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cyto.2015.05.030","volume":"75","author":"P Bhattacharya","year":"2015","unstructured":"Bhattacharya P, Thiruppathi M, Elshabrawy HA, Alharshawi K, Kumar P, Prabhakar BS (2015) GM-CSF: An immune modulatory cytokine that can suppress autoimmunity. Cytokine 75(2):261\u2013271. https:\/\/doi.org\/10.1016\/j.cyto.2015.05.030","journal-title":"Cytokine"},{"issue":"2","key":"12175_CR26","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3892\/etm.2019.7641","volume":"18","author":"J Guo","year":"2019","unstructured":"Guo J, Liu J (2019) Effect of white mange mixture in a murine model of psoriasis. Experimental therapeutic Med 18(2):881\u2013887. https:\/\/doi.org\/10.3892\/etm.2019.7641","journal-title":"Experimental therapeutic Med"},{"key":"12175_CR27","doi-asserted-by":"publisher","first-page":"1158859","DOI":"10.3389\/fimmu.2023.1158859","volume":"14","author":"Y Chen","year":"2023","unstructured":"Chen Y, Li F, Hua M, Liang M, Song C (2023) Role of GM-CSF in lung balance and disease. Front Immunol 14:1158859. https:\/\/doi.org\/10.3389\/fimmu.2023.1158859","journal-title":"Front Immunol"},{"key":"12175_CR28","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1084\/jem.20091844","volume":"207","author":"IL King","year":"2010","unstructured":"King IL, Kroenke MA, Segal BM (2010) GM-CSF-dependent, CD103\u2009+\u2009dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization. J Exp Med 207:953\u2013961. https:\/\/doi.org\/10.1084\/jem.20091844","journal-title":"J Exp Med"},{"key":"12175_CR29","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3389\/fimmu.2019.01265","volume":"10","author":"N Lotfi","year":"2019","unstructured":"Lotfi N, Thome R, Rezaei N, Zhang GX, Rezaei A, Rostami A, Esmaeil N (2019) Roles of GM-CSF in the pathogenesis of autoimmune diseases: an update. Front Immunol 10:1265. https:\/\/doi.org\/10.3389\/fimmu.2019.01265","journal-title":"Front Immunol"},{"issue":"1","key":"12175_CR30","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.21608\/ejhc.2024.346001","volume":"15","author":"IAE Kader","year":"2024","unstructured":"Kader IAE, Ahmed Ibrahim A, F., Salime AAEM, R (2024) Psoriasis severity and functional disabilities among patients with psoriasis. Egypt J Health Care 15(1):1358\u20131370. https:\/\/ejhc.journals.ekb.eg\/article_346001.html","journal-title":"Egypt J Health Care"},{"key":"12175_CR31","doi-asserted-by":"publisher","unstructured":"Rigopoulos D, Katsantonis J, Neofotistou O, Chasapi V, Lazaridou E, Roussaki-Schulze AV et al (2025) Psoriasis severity in moderate to severe psoriatic Greek patients routinely treated with systemic treatment: a cross-sectional and retrospective chart review study (CRYSTAL-Greece). Journal of Dermatological Treatment, 36(1). https:\/\/doi.org\/10.1080\/09546634.2024.2402344","DOI":"10.1080\/09546634.2024.2402344"},{"key":"12175_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s12033-014-9734-4","volume":"56","author":"RFV Medrano","year":"2014","unstructured":"Medrano RFV, De Oliveira CA (2014) Guidelines for the tetra-primer ARMS-PCR technique development. Mol Biotechnol 56:599\u2013608. https:\/\/doi.org\/10.1007\/s12033-014-9734-4","journal-title":"Mol Biotechnol"},{"key":"12175_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3352\/jeehp.2021.18.17","volume":"18","author":"H Kang","year":"2021","unstructured":"Kang H (2021) Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof 18:17","journal-title":"J Educ Eval Health Prof"},{"issue":"4","key":"12175_CR34","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1097\/JW9.0000000000000112","volume":"9","author":"A Gonzalez-Cantero","year":"2023","unstructured":"Gonzalez-Cantero A, Constantin MM, Dattola A, Hillary T, Kleyn E, Magnolo N (2023) Gender perspective in psoriasis: a scoping review and proposal of strategies for improved clinical practice by European dermatologists. Int J Womens Dermatol 9(4):e112. https:\/\/doi.org\/10.1097\/JW9.0000000000000112","journal-title":"Int J Womens Dermatol"},{"key":"12175_CR35","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1136\/annrheumdis-2023-eular.3247","volume":"82","author":"B Firlatan","year":"2023","unstructured":"Firlatan B, Bayram GK, Ayan G, Kalyoncu U (2023) AB1149 Sex distribution in psoriatic arthritis: systematic literature review. Ann Rheum Dis 82:1805. https:\/\/doi.org\/10.1136\/annrheumdis-2023-eular.3247","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"12175_CR36","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/1346-8138.16733","volume":"50","author":"C Ohata","year":"2023","unstructured":"Ohata C, Anezaki H, Kaneko S, Okazaki F, Ito K, Matsuzaka Y, Kikuchi S, Koike Y, Murota H, Miyagi T, Takahashi K, Sugita K, Hashimoto A, Nakahara T, Morizane S, Ohyama B, Saruwatari H, Yanase T, Yoshida Y, Yonekura K, Higashi Y, Hatano Y, Saito K, Katayama E, Yamane M, Yamazaki F, Tsuruta N, Imafuku S (2023) Clinical characteristics of patients with psoriasis with family history: A multicenter observational study. J Dermatol 50(6):746\u2013752. https:\/\/doi.org\/10.1111\/1346-8138.16733","journal-title":"J Dermatol"},{"issue":"1","key":"12175_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/acr.23836","volume":"72","author":"D Solmaz","year":"2020","unstructured":"Solmaz D, Bakirci S, Kimyon G, Gunal EK, Dogru A, Bayindir O, Dalkilic E, Ozisler C, Can M, Akar S, Cetin GY, Yavuz S, Kilic L, Tarhan EF, Kucuksahin O, Omma A, Gonullu E, Yildiz F, Ersozlu ED, Cinar M, Al-Onazi A, Erden A, Tufan MA, Yilmaz S, Pehlevan S, Kalyoncu U, Aydin SZ (2020) Impact of having family history of psoriasis or psoriatic arthritis on psoriatic disease. Arthritis Care Res (Hoboken) 72(1):63\u201368. https:\/\/doi.org\/10.1002\/acr.23836","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"12175_CR38","doi-asserted-by":"publisher","first-page":"891","DOI":"10.2147\/CCID.S453078","volume":"17","author":"F Jiang","year":"2024","unstructured":"Jiang F, Lu L, Wang S, Yuan F, Cao L, Xu S, Lin B (2024) Relationship Between Family History and Quality of Life in Patients with Psoriasis: A Cross-Sectional Study from China. Clin Cosmet Invest Dermatology 17:891\u2013900. https:\/\/doi.org\/10.2147\/CCID.S453078","journal-title":"Clin Cosmet Invest Dermatology"},{"key":"12175_CR39","doi-asserted-by":"publisher","first-page":"1410540","DOI":"10.3389\/fimmu.2024.1410540","volume":"15","author":"L Raam","year":"2024","unstructured":"Raam L, Hartmane I, Valiukevi\u010dien\u0117 S, Karamova AE, Telegdy E, Botev I, Marina D, Rubant S, Albuquerque T, Constantin MM (2024) Disease severity, treatment patterns, and quality of life in patients with moderate-to-severe psoriasis routinely managed with systemic treatment: results of the crystal observational study in Central and Eastern European countries. Front Immunol 15:1410540. https:\/\/doi.org\/10.3389\/fimmu.2024.1410540","journal-title":"Front Immunol"},{"issue":"8","key":"12175_CR40","doi-asserted-by":"publisher","first-page":"e43790","DOI":"10.7759\/cureus.43790","volume":"15","author":"G \u015eener","year":"2023","unstructured":"\u015eener G, \u0130nan Yuksel E, G\u00f6kdeniz O, Karaman K, Canat HD (2023) The Relationship of Hematological Parameters and C-reactive Protein (CRP) With Disease Presence, Severity, and Response to Systemic Therapy in Patients With Psoriasis. Cureus 15(8):e43790. https:\/\/doi.org\/10.7759\/cureus.43790","journal-title":"Cureus"},{"issue":"1","key":"12175_CR41","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/life14010114","volume":"14","author":"OM Tiuc\u0103","year":"2024","unstructured":"Tiuc\u0103 OM, Morariu SH, Mariean CR, Tiuc\u0103 RA, Nicolescu AC, Cotoi OS (2024) Impact of Blood-Count-Derived Inflammatory Markers in Psoriatic Disease Progression. Life 14(1):114. https:\/\/doi.org\/10.3390\/life14010114","journal-title":"Life"},{"issue":"5","key":"12175_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3892\/etm.2024.12497","volume":"27","author":"Y Yao","year":"2024","unstructured":"Yao Y, Zeng L, Huang X, Zhang J, Zhang G, Wang L (2024) Role of co-inhibitory molecules in the treatment of psoriasis. Experimental Therapeutic Med 27(5):209. https:\/\/doi.org\/10.3892\/etm.2024.12497","journal-title":"Experimental Therapeutic Med"},{"issue":"3","key":"12175_CR43","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3390\/jcm9030877","volume":"9","author":"D-P Chen","year":"2020","unstructured":"Chen D-P, Lin W-T, Wang W-T, Chiueh T-S (2020) The influence of CD28 gene polymorphism in transfusion reaction after transfusing leukoreduced blood components. J Clin Med 9(3):877. https:\/\/doi.org\/10.3390\/jcm9030877","journal-title":"J Clin Med"},{"issue":"2","key":"12175_CR44","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1365-2249.2004.02427.x","volume":"136","author":"PY Hatron","year":"2004","unstructured":"Hatron PY, Hachulla E, Devulder B, Bonnefoy JY, Delneste Y (2004) Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sj\u00f6gren\u2019s syndrome and systemic sclerosis. Clin Exp Immunol 136(2):388\u2013392. https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02427.x","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"12175_CR45","doi-asserted-by":"publisher","first-page":"e23188","DOI":"10.1002\/jcla.23188","volume":"34","author":"M Garc\u00eda-Chagoll\u00e1n","year":"2020","unstructured":"Garc\u00eda-Chagoll\u00e1n M, Ledezma\u2010Lozano IY, Hern\u00e1ndez\u2010Bello J, S\u00e1nchez\u2010Hern\u00e1ndez PE, Guti\u00e9rrez\u2010Ure\u00f1a SR, Mu\u00f1oz\u2010Valle JF (2020) Expression patterns of CD28 and CTLA\u20104 in early, chronic, and untreated rheumatoid arthritis. J Clin Lab Anal 34(5):e23188. https:\/\/doi.org\/10.1002\/jcla.23188","journal-title":"J Clin Lab Anal"},{"key":"12175_CR46","doi-asserted-by":"publisher","unstructured":"Zahra\u2019a AA, Alrawi PAA (2022) Evaluation of IL-35 and IL-39 in rheumatoid arthritis. J Fac Med Baghdad 64(3). https:\/\/doi.org\/10.32007\/jfacmedbagdad.6431963","DOI":"10.32007\/jfacmedbagdad.6431963"},{"key":"12175_CR47","doi-asserted-by":"publisher","unstructured":"Al Ghuraibawi ZAG, Sharquie IK, Gorial FI (2023) A novel link of serum IL-39 levels in patients with rheumatoid arthritis. Iraqi J Sci 1651\u20131661. https:\/\/doi.org\/10.24996\/ijs.2023.64.4.8","DOI":"10.24996\/ijs.2023.64.4.8"},{"key":"12175_CR48","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13075-024-03373-y","volume":"26","author":"J Su","year":"2024","unstructured":"Su J, Hu W, Ding Y et al (2024) Serum GM-CSF level is a predictor of treatment response to tocilizumab in rheumatoid arthritis patients: a prospective observational cohort study. Arthritis Res Ther 26:130. https:\/\/doi.org\/10.1186\/s13075-024-03373-y","journal-title":"Arthritis Res Ther"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12175-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12175-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12175-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:06:54Z","timestamp":1782562014000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12175-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12175"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12175-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}}],"article-number":"1013"}}